Lakefront Biotherapeutics NV (LKFT)
NASDAQ: LKFT · Real-Time Price · USD
29.50
+0.66 (2.29%)
At close: Jun 26, 2026, 4:00 PM EDT
29.48
-0.02 (-0.07%)
After-hours: Jun 26, 2026, 4:10 PM EDT
LKFT Employees
Lakefront Biotherapeutics NV had 558 employees as of June 30, 2025. The number of employees decreased by 146 or -20.74% since the number was reported on December 31, 2024.
Employees
558
Change
-146
Growth
-20.74%
Revenue / Employee
$2,156,720
Profits / Employee
$1,009,971
Market Cap
1.93B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Harmony Biosciences Holdings | 293 |
| Viridian Therapeutics | 252 |
| Monte Rosa Therapeutics | 187 |
| Stoke Therapeutics | 170 |
| Precigen | 160 |
| Tyra Biosciences | 87 |
| Rapport Therapeutics | 84 |
LKFT News
- 4 days ago - Acquisition of Own Shares - GlobeNewsWire
- 18 days ago - Lakefront Biotherapeutics announces EUR 50M share repurchase program - TheFly
- 18 days ago - Lakefront Announces Initiation of €50 Million Stock Repurchase Program - GlobeNewsWire
- 19 days ago - Lakefront Biotherapeutics appoints Eric Hedrick chief medical officer - TheFly
- 19 days ago - Lakefront Appoints Eric Hedrick, MD, as Chief Medical Officer - GlobeNewsWire